MCKENNA SPILLAR: Open Payments
NPI 1114651924 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 40 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $333 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $312 |
| ABBVIE INC. | 12 | $198 |
| Janssen Biotech, Inc. | 4 | $92 |
| Phathom Pharmaceuticals, Inc. | 2 | $90 |
| Enterra Medical, Inc. | 1 | $78 |
| GENZYME CORPORATION | 2 | $44 |
| QOL Medical, LLC | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Madrigal Pharmaceuticals | 1 | $17 |
Products named: ENTYVIO, EOHILIA, LINZESS, TREMFYA, VOQUEZNA, DUPIXENT, RINVOQ, Sucraid.
Industry payments across WY — which companies pay providers there.
